Pituitary disorders

Reading File
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Reading File
Finding Sources
Excellent content gathered. I now have enough comprehensive material to write a thorough exam-prep overview of all pituitary disorders. Let me compile the full answer.

Pituitary Disorders - Comprehensive Exam Review

Hypothalamic-Pituitary Axis
Hypothalamic-pituitary structural and functional relationships (Goldman-Cecil Medicine)

Anatomy & Physiology Recap

The pituitary sits in the sella turcica and has two lobes:
LobeHormonesBlood Supply
Anterior (adenohypophysis)GH, PRL, TSH, ACTH, LH, FSHHypophyseal portal venous system (low-pressure)
Posterior (neurohypophysis)ADH (vasopressin), OxytocinDirect arterial branches
The anterior pituitary is the "command center" regulating adrenal, thyroid, and gonads. The posterior pituitary is an extension of hypothalamic neurons - oxytocin and vasopressin are produced in the hypothalamus and transported down axons for storage and release.
Key regulatory principle: Hypothalamic releasing hormones stimulate anterior pituitary secretion; dopamine tonically inhibits prolactin.

I. HYPERPITUITARISM (Excess Hormone Secretion)

Pituitary Adenomas - The Core Concept

The most common cause of hyperpituitarism is an anterior lobe pituitary adenoma (neuroendocrine tumor). Key exam facts:
  • Microadenoma = <1 cm | Macroadenoma = >1 cm
  • Macroadenomas cause mass effects (especially visual disturbances via optic chiasm compression - bitemporal hemianopia)
  • Genetic mutation: GNAS gene mutation causing constitutive activation of stimulatory G protein (one of the more common alterations)
  • Morphology: cellular monomorphism + absence of reticulin network are the two distinctive features
  • Pituitary carcinomas are exceedingly rare; they extend beyond the sella and metastasize
- Robbins & Kumar Basic Pathology

A. Prolactinoma (Lactotroph Adenoma)

Most common functional pituitary adenoma.
Clinical features:
  • Women: amenorrhea, infertility, galactorrhea (the classic triad)
  • Men: impotence, loss of libido, infertility (often present late with CNS compression symptoms - headaches, visual defects)
  • Galactorrhea associated with amenorrhea is a self-limiting disorder with moderately elevated PRL
Diagnosis:
  • PRL >200 µg/L almost invariably indicates a prolactin-secreting adenoma
  • PRL <100 µg/L - may be microadenoma, other sellar lesion, or non-neoplastic cause
  • MRI should be performed in all patients with hyperprolactinemia
Other causes of hyperprolactinemia to exclude (exam favorite):
  • Drugs: dopamine receptor blockers (haloperidol, chlorpromazine, risperidone), metoclopramide, verapamil, opiates, TCAs, SSRIs (fluoxetine), estrogens, cimetidine
  • Physiologic: pregnancy, breastfeeding
  • Hypothyroidism (TRH stimulates PRL)
  • Chronic renal failure, cirrhosis
Treatment:
  • Dopamine agonists (cabergoline, bromocriptine) are the mainstay
  • Cabergoline (0.5-1.0 mg twice weekly) - achieves normoprolactinemia in ~80% of microadenomas, shrinks ~70% of macroadenomas
  • Cabergoline is preferred over bromocriptine (longer-acting, higher D2 affinity, better tolerated)
  • Microadenomas: may just monitor if asymptomatic and no fertility desire
  • After 2 years of normoprolactinemia with microadenoma - can try withdrawing dopamine agonist (monitor carefully for recurrence)
  • ~20% of patients (especially males) are resistant to dopaminergic treatment
- Harrison's Principles of Internal Medicine 22E

B. Somatotroph Adenoma (GH-secreting)

Clinical manifestations:
  • Gigantism - if excess GH occurs before epiphyseal closure (children)
  • Acromegaly - if excess GH occurs after epiphyseal closure (adults): coarsening of facial features, enlarged hands/feet, prognathism, macroglossia, organomegaly
  • Impaired glucose tolerance and diabetes mellitus (GH is insulin-antagonistic)
  • Associated with galactorrhea in ~1/3 of patients
- Robbins & Kumar Basic Pathology

C. Corticotroph Adenoma (ACTH-secreting) - "Cushing Disease"

Key distinction:
  • Cushing Disease = pituitary ACTH-secreting adenoma (the cause)
  • Cushing Syndrome = clinical syndrome from any cause of glucocorticoid excess
Clinical features of Cushing syndrome:
  • Central obesity, moon face, buffalo hump
  • Striae (purple/red), thin skin, easy bruising
  • Proximal muscle weakness, osteoporosis
  • Hypertension, hyperglycemia
  • Hypokalemia (from mineralocorticoid effects of excess cortisol)
  • Hyperpigmentation (from excess ACTH stimulating MSH from same POMC precursor)
Adenoma features: Also produces melanocyte-stimulating hormone (MSH) from the same POMC precursor, causing hyperpigmentation.
- Robbins & Kumar Basic Pathology

D. Other Functional Adenomas

Adenoma TypeHormoneClinical Syndrome
ThyrotrophTSHSecondary hyperthyroidism (rare)
GonadotrophLH/FSHUsually nonfunctional clinically; mass effects
Null cellNoneMass effects only

II. HYPOPITUITARISM

Definition: Deficiency of one or more anterior pituitary hormones. Prevalence: 290-455 cases per million; incidence: 42 cases per million per year. Panhypopituitarism = defect in all pituitary hormone lines.

Causes

CategorySpecific Cause
Tumors (most common)Nonfunctioning macroadenoma compressing normal pituitary
Ischemic necrosisSheehan syndrome (post-partum), DIC, sickle cell anemia, shock
IatrogenicSurgery, radiation
InflammationSarcoidosis, tuberculosis
TraumaHead injury
MetastasesBreast, lung
GeneticTranscription factor mutations (Pit-1, PROP1, TPIT, etc.)
Sheehan Syndrome (key exam topic): Postpartum pituitary necrosis.
  • Mechanism: The anterior pituitary enlarges during pregnancy (increase in prolactin-secreting cells) but portal venous blood supply does NOT increase proportionately. This makes it vulnerable to ischemic injury during obstetric hemorrhage/hypotension.
  • Posterior pituitary is protected - receives direct arterial supply - so DI from Sheehan is uncommon
  • Panhypopituitarism follows as a result

Clinical Manifestations (by hormone lost)

Hormone DeficientClinical Effect
GHGrowth failure in children; fatigue, reduced muscle mass in adults
FSH/LH (gonadotropins)Amenorrhea, infertility (women); impotence, loss of libido, loss of pubic/axillary hair (men)
TSHSecondary hypothyroidism
ACTHSecondary hypoadrenalism (life-threatening if missed)
PRLFailure of postpartum lactation
MSH (from ACTH precursor)Skin pallor (loss of melanocyte stimulation)
Important: In primary adrenal insufficiency - hyperpigmentation. In secondary (ACTH deficiency from pituitary) - skin pallor. This is a classic distinction.
- Robbins & Kumar Basic Pathology; Goldman-Cecil Medicine; Harrison's

III. POSTERIOR PITUITARY DISORDERS

A. Diabetes Insipidus (DI)

Cause: ADH (vasopressin) deficiency or resistance
TypeMechanismCause
Central DIADH deficiencyHead trauma, neoplasms, inflammatory disorders, surgery, idiopathic
Nephrogenic DIRenal tubular unresponsiveness to ADHGenetic, lithium, hypercalcemia
Clinical features:
  • Polyuria (large volumes of dilute urine, low specific gravity)
  • Polydipsia
  • Increased serum Na and osmolality
  • Risk of life-threatening dehydration if unable to drink
Key test: Water deprivation test + ADH response (central DI responds to exogenous ADH; nephrogenic does not)

B. SIADH (Syndrome of Inappropriate ADH Secretion)

Cause: ADH overproduction
Common causes:
  • Ectopic ADH from malignant neoplasms - particularly small cell carcinoma of the lung (most classic)
  • Non-neoplastic pulmonary diseases
  • CNS injury/hypothalamic damage
  • Drugs (SSRIs, carbamazepine, etc.)
Clinical features:
  • Hyponatremia (dilutional) - the dominant feature
  • Cerebral edema and neurologic dysfunction
  • Normal or slightly increased total body water
  • Blood volume stays normal - no peripheral edema (key distinguishing feature)
- Robbins & Kumar Basic Pathology

IV. CRANIOPHARYNGIOMA

A distinct, separate entity - not an adenoma but an important pituitary-region tumor for exams.
  • Derived from remnants of Rathke's pouch
  • Suprasellar location, often with calcification (visible on CT)
  • Bimodal age distribution: children (5-15 yrs) and adults (45-60 yrs)
  • Clinical effects: hypopituitarism, visual field defects (chiasm), hydrocephalus
  • Adamantinomatous type (children) - contains cholesterol-rich "machine oil" fluid and calcification
  • Papillary type (adults) - associated with BRAF V600E mutation

V. EMPTY SELLA SYNDROME

  • Sella filled with CSF; pituitary is compressed against its wall
  • Primary (defect in diaphragma sellae) or secondary (post-surgery/radiation/infarction)
  • Usually asymptomatic but can cause mild hypopituitarism
  • Hyperprolactinemia can occur due to stretch on pituitary stalk

Quick Summary Table (High-Yield for Exams)

ConditionKey HormoneClassic PresentationTreatment
Prolactinoma↑ PRLAmenorrhea + galactorrhea (F); impotence (M)Cabergoline/bromocriptine
Acromegaly↑ GHEnlarged acral parts, DM, coarse featuresSurgery (transsphenoidal)
Cushing disease↑ ACTHCentral obesity, striae, hyperglycemiaSurgery
Hypopituitarism↓ multipleDepends on deficient hormone; ACTH loss = most dangerousHormone replacement
Sheehan syndrome↓ multiplePost-partum failure to lactateHormone replacement
Central DI↓ ADHPolyuria, polydipsia, ↑ NaDesmopressin (DDAVP)
SIADH↑ ADH effectHyponatremia, ↓ serum osmolalityFluid restriction; treat cause
CraniopharyngiomaMass effectVisual field defect + hypopituitarism + calcification on CTSurgery

Exam Mnemonics & High-Yield Points

  1. "Bitemporal hemianopia" = always think pituitary/suprasellar lesion (optic chiasm compression)
  2. PRL >200 µg/L = prolactinoma until proven otherwise
  3. Sheehan = postpartum + can't breastfeed + amenorrhea (failure of all anterior pituitary)
  4. SIADH + small cell lung cancer = classic pair
  5. Acromegaly in adults, gigantism in children (same adenoma, different epiphyseal status)
  6. Cushing Disease vs Syndrome: Disease = pituitary; Syndrome = any cause
  7. Skin pallor in hypopituitarism (↓ MSH) vs hyperpigmentation in Addison's (↑ ACTH/MSH)
  8. Central DI responds to DDAVP; nephrogenic does not
  9. Cabergoline preferred over bromocriptine for prolactinoma (longer half-life, better efficacy)
  10. GNAS mutation in somatotroph adenomas (constitutive Gs activation → ↑ cAMP → ↑ GH)

Sources: Robbins & Kumar Basic Pathology; Goldman-Cecil Medicine; Harrison's Principles of Internal Medicine 22E; Robbins Cotran Pathologic Basis of Disease
This is a shared conversation. Sign in to Orris to start your own chat.